Rheumatoid Arthritis Clinical Trials in Chicago, Illinois

5 studies are recruiting for rheumatoid arthritis in Chicago, Illinois right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

   This phase Ib trial studies the side effects of nivolumab and to see how well it works alone and in combination with other treatments, such as ipilimumab, cabozantinib, platinum containing therapy, and fluoropyrimidine, in treating patients with autoimmune disorders and cancer that has spread from …

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Northwestern University, Chicago, Illinois

   Locations

   52 in total

   Run by

   National Cancer Institute (NCI)

   See if you can join NCT03816345 on ClinicalTrials.gov

2. A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

   This is a Phase 1/2, open-label, multi-center, multi-cohort, non-randomized dose escalation and dose expansion basket study to determine the safety and tolerability of NKX019 (allogeneic CAR NK cells targeting CD19) in participants with autoimmune diseases.

   Stage

   Phase 1

   Ages

   18 to 75

   Site

   Nkarta Investigational Site, Chicago, Illinois

   Locations

   18 in total

   Run by

   Nkarta, Inc.

   See if you can join NCT06733935 on ClinicalTrials.gov

3. A Study of AZD0120 in Autoimmune Diseases

   This trial is a Phase 1b, open-label, multi-center, clinical study of AZD0120, a BCMA/CD19 dual targeting CAR+ T-cell therapy, to evaluate the safety and tolerability in adult participants with systemic sclerosis (SSc), idiopathic inflammatory myopathies (IIM), or difficult-to-treat rheumatoid arth…

   Stage

   Phase 1

   Ages

   18 to 75

   Site

   Research Site, Chicago, Illinois

   Locations

   22 in total

   Run by

   AstraZeneca

   See if you can join NCT07295847 on ClinicalTrials.gov

4. A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis

   Rheumatoid Arthritis (RA) is a chronic inflammatory disease causing pain, stiffness, swelling and loss of joint function. This study will evaluate the efficacy and safety of targeted therapies through a series of substudies for the treatment of moderately to severely active Rheumatoid Arthritis (RA…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Northwestern Medicine - Northwestern Memorial Hospital /ID# 275422, Chicago, Illinois

   Locations

   104 in total

   Run by

   AbbVie

   See if you can join NCT06972446 on ClinicalTrials.gov

5. Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis

   This study will test the safety and effects of SBT777101 when given as a single dose to subjects with rheumatoid arthritis. It is the first study of this treatment being done in humans. Increasing dose levels will be given after the safety at lower dose levels is shown. Following completion of the …

   Stage

   Phase 1

   Ages

   18 to 70

   Site

   Northwestern University, Chicago, Illinois

   Locations

   9 in total

   Run by

   Sonoma Biotherapeutics, Inc.

   See if you can join NCT06201416 on ClinicalTrials.gov